leadf
logo-loader
NASDAQ:ENVB FRA:SLZ

Enveric Biosciences

Receive alerts
Market:
NASDAQ
Market Cap:
$48.01 m
Price
2.24 USD
Change
2.28%
52 weeks high
7.00
52 weeks low
1.54

In brief

Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments.

The company has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.